These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38658426)

  • 1. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
    Bay P; Audureau E; Préau S; Favory R; Guigon A; Heming N; Gault E; Pham T; Chaghouri A; Turpin M; Morand-Joubert L; Jochmans S; Pitsch A; Meireles S; Contou D; Henry A; Joseph A; Chaix ML; Uhel F; Roux D; Descamps D; Emery M; Garcia-Sanchez C; Levy D; Burrel S; Mayaux J; Kimmoun A; Hartard C; Pène F; Rozenberg F; Gaudry S; Brichler S; Guillon A; Handala L; Tamion F; Moisan A; Daix T; Hantz S; Delamaire F; Thibault V; Souweine B; Henquell C; Picard L; Botterel F; Rodriguez C; Dessap AM; Pawlotsky JM; Fourati S; de Prost N;
    Ann Intensive Care; 2024 Apr; 14(1):65. PubMed ID: 38658426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
    Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
    Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
    Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
    J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
    Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
    Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
    J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
    Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
    Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
    Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
    Chong WH; Saha BK; Neu KP
    Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
    Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
    Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
    Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J
    Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
    Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
    BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
    Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
    Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Pulmonary Aspergillosis and
    Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.